Antibacterial carbon dots
Source abstract
Abstract
Bacterial infections significantly threaten human health, leading to severe diseases and complications across multiple systems and organs. Antibiotics remain the primary treatment strategy for these infections. However, the growing resistance of bacteria to conventional antibiotics underscores the urgent need for safe and effective alternative treatments. In response, several approaches have been developed, including carbon dots (CDs), antimicrobial peptides, and antimicrobial polymers, all of which have proven effective in combating bacterial resistance. Among these, CDs stand out due to their unique advantages, including low preparation cost, stable physicochemical properties, high biocompatibility, tunable surface chemistry, strong photoluminescence, and efficient generation of reactive oxygen species. These features make CDs highly promising in antibacterial applications. This review explores the development of antibacterial CDs, focusing on their mechanisms of action-physical destroy, biochemical damage, and synergistic effects-while highlighting their potential for clinical use as antibacterial agents.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Carbon and Quantum Dots Applications · Nanocluster Synthesis and Applications · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Short-course antibiotics for common infections: What do we know and where do we go from here?10.1016/j.cmi.2022.08.024 ↗
2. Pneumonia, meningitis, and septicemia in adults and older children in Rural Gambia: 8 years of population-based surveillance10.1093/cid/ciac603 ↗
3. Fatal Listeria monocytogenes septicemia and meningitis complicated by Candida glabrata fungemia: A case report10.1080/03007995.2022.2120689 ↗
4. Global prevalence of Post-Coronavirus disease 2019 (COVID-19) condition or long COVID: A meta-analysis and systematic review10.1093/infdis/jiac136 ↗
5. The prevalence of mental health conditions in healthcare workers during and after a pandemic: Systematic review and meta-analysis10.1111/jan.15175 ↗
6. Neutral red/carbon dots photodynamic disinfectant spray for sports mouthguards cleaning and perishable foods preservation
7. A robust carbon dot-based antibacterial CDs-PVA film as a wound dressing for antibiosis and wound healing10.1039/D2TB02582E ↗
8. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia
9. Flourishing antibacterial strategies for osteomyelitis therapy10.1002/advs.202206154 ↗
10. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide10.1053/j.gastro.2018.12.005 ↗
11. Real-time biosynthetic reaction monitoring informs the mechanism of action of antibiotics10.1021/jacs.4c00081 ↗
12. Antibiotics in the pipeline: A literature review (2017–2020)
13. Combating antimicrobial resistance: A paradigm shift from general to precision medicine
14. Role of alternatives to antibiotics in mitigating the antimicrobial resistance crisis10.4103/ijmr.IJMR_3514_20 ↗
15. A review on the alternatives to antibiotics and the treatment of antibiotic pollution: Current development and future prospects10.1016/j.scitotenv.2024.171757 ↗
16. Biomaterial-based antimicrobial therapies for the treatment of bacterial infections10.1038/s41578-021-00362-4 ↗
17. Recent advances in bacteriophage-based therapeutics: Insight into the post-antibiotic era10.1016/j.apsb.2022.05.007 ↗
18. Triggered release of antimicrobial peptide from microneedle patches for treatment of wound biofilms10.1016/j.jconrel.2023.02.030 ↗
19. Antimicrobial peptides for combating drug-resistant bacterial infections10.1016/j.drup.2023.100954 ↗
20. Identification of potent antimicrobial peptides via a machine-learning pipeline that mines the entire space of peptide sequences10.1038/s41551-022-00991-2 ↗
21. Phage therapy for antibiotic-resistant bacterial infections10.1146/annurev-med-080219-122208 ↗
22. Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae10.1038/s41467-021-27656-z ↗
23. Degradable pseudo conjugated polymer nanoparticles with NIR-II photothermal effect and cationic quaternary phosphonium structural bacteriostasis for anti-infection therapy10.1002/advs.202200732 ↗
24. Recent advances in engineered polymeric materials for efficient photodynamic inactivation of bacterial pathogens
25. Recent advances in polymers and polymer composites for food packaging10.1016/j.mattod.2022.01.022 ↗
26. Size-dependent antibacterial of carbon dots by selective absorption and differential oxidative stress of bacteria10.1016/j.jcis.2022.12.025 ↗
27. Highly fluorescent N, F co-doped carbon dots with tunable light emission for multicolor bio-labeling and antibacterial applications10.1016/j.jhazmat.2023.132331 ↗
28. The preparation of chiral carbon dots and the study on their antibacterial abilities10.1016/j.matchemphys.2022.127144 ↗
29. Electrophoretic analysis and purification of fluorescent single-walled carbon nanotube fragments10.1021/ja040082h ↗
30. Quantum-sized carbon dots for bright and colorful photoluminescence10.1021/ja062677d ↗
31. Metal nanoparticles/carbon dots nanocomposites for SERS devices: Trends and perspectives
32. The development of carbon dots: From the perspective of materials chemistry10.1016/j.mattod.2021.07.028 ↗
33. Carbon dots based photoinduced reactions: Advances and perspective10.1002/advs.202207621 ↗
34. An overview on carbon quantum dots optical and chemical features10.3390/molecules28062772 ↗
35. Synthetic routes to theranostic applications of carbon-based quantum dots
36. Synthesis mechanisms, structural models, and photothermal therapy applications of top-down carbon dots from carbon powder, graphite, graphene, and carbon nanotubes10.3390/ijms23031456 ↗
37. Divergence in antiviral activities of carbon dots versus nano-carbon/organic hybrids and implications
38. Biogenic carbon quantum dots: Synthesis and applications10.2174/0929867330666230608105201 ↗
39. Injectable self-healing hydrogel fabricated from antibacterial carbon dots and ɛ-polylysine for promoting bacteria-infected wound healing
40. Positively charged BODIPY@carbon dot nanocomposites for enhanced photomicrobicidal efficacy and wound healing10.1039/D2TB01539K ↗
41. Development of xanthoangelol-derived compounds with membrane-disrupting effects against Gram-positive bacteria10.3390/antibiotics13080744 ↗
42. Ultrasound-responsive catalytic microbubbles enhance biofilm elimination and immune activation to treat chronic lung infections10.1126/sciadv.ade5446 ↗
43. Recent advances in peptidoglycan synthesis and regulation in bacteria10.3390/biom13050720 ↗
44. Gold nanoparticle adsorption alters the cell stiffness and cell wall bio-chemical landscape of Candida albicans fungal cells10.1016/j.jcis.2023.10.017 ↗
45. High antibacterial activity of spermine functionalized carbon dots and its potential application in sausage preservation10.1007/s11947-023-03091-4 ↗
46. Plasma membrane-cell wall feedback in bacteria10.1128/jb.00433-22 ↗
47. Cell envelope growth of Gram-negative bacteria proceeds independently of cell wall synthesis10.15252/embj.2022112168 ↗
48. Flourishing antibacterial strategies for osteomyelitis therapy10.1002/advs.202206154 ↗
49. Targeting membrane-bound bacterial cell wall precursors: A tried and true antibiotic strategy in nature and the clinic10.1039/D3CC01070H ↗
50. Structure-activity correlations for antibacterial agents on Gram-positive and Gram-negative cells10.1021/jm00309a004 ↗
51. Does the electrical double layer contribute to the mechanism of action of antimicrobial peptides?10.1002/celc.202400153 ↗
52. Carbon dots with positive surface charge from tartaric acid and m-aminophenol for selective killing of Gram-positive bacteria10.1039/D0TB02332A ↗
53. Daptomycin liposomes exhibit enhanced activity against staphylococci biofilms compared to free drug10.3390/pharmaceutics16040459 ↗
54. Quaternized silicon nanoparticles with polarity-sensitive fluorescence for selectively imaging and killing Gram-positive bacteria10.1002/adfm.201602185 ↗
55. Enhanced antibacterial activity against escherichia coli based on cationic carbon dots assembling with 5-aminolevulinic acid10.1021/acsomega.3c08914 ↗
56. Long-term antibacterial activity of guanidinium carbon dots without detectable resistance for the effective treatment of pneumonia caused by Gram-negative bacteria10.1016/j.carbon.2023.118229 ↗
57. The role of endotoxin in septic shock10.1186/s13054-023-04690-5 ↗
58. Polysaccharide-targeting lipid nanoparticles to kill Gram-negative bacteria10.1002/smll.202305052 ↗
59. Long-term antibacterial activity of guanidinium carbon dots without detectable resistance for the effective treatment of pneumonia caused by Gram-negative bacteria10.1016/j.carbon.2023.118229 ↗
60. Surveying membrane landscapes: A new look at the bacterial cell surface10.1038/s41579-023-00862-w ↗
61. Inhibition of multiple staphylococcal growth states by a small molecule that disrupts membrane fluidity and voltage10.1128/msphere.00772-23 ↗
62. Biofunctional lipid nanoparticles for precision treatment and prophylaxis of bacterial infections10.1126/sciadv.adk9754 ↗
63. Application of carbon dots as antibacterial agents: A mini review10.1007/s12668-024-01415-y ↗
64. Screening of chitosan derivatives-carbon dots based on antibacterial activity and application in anti-staphylococcus aureus biofilm10.2147/IJN.S350739 ↗
65. Synthesis of curcumin-quaternized carbon quantum dots with enhanced broad-spectrum antibacterial activity for promoting infected wound healing
66. Multiobjective-optimization MoS2/Cd-ZnIn2S4/CdS composites prepared by in situ structure-tailored technique for high-efficiency hydrogen generation10.1002/sstr.202300569 ↗
67. Tuning polar discrimination between side chains to improve the performance of anion exchange membranes10.1016/j.jcis.2024.03.117 ↗
68. Molecular engineering of fluorescent dyes for long-term specific visualization of the plasma membrane based on alkyl-chain-regulated cell permeability10.1016/j.talanta.2024.126105 ↗
69. Extraribosomal functions of bacterial ribosomal proteins-an update10.3390/ijms25052957 ↗
70. Bacterial chromatin proteins, transcription, and DNA topology: Inseparable partners in the control of gene expression10.1111/mmi.15283 ↗
71. Overview of bacterial protein toxins from pathogenic bacteria: Mode of action and insights into evolution10.3390/toxins16040182 ↗
72. Targeting mycobacterial membranes and membrane proteins: Progress and limitations10.1016/j.bmc.2023.117212 ↗
73. Discovery of endosomalytic cell-penetrating peptides based on bacterial membrane-targeting sequences10.1016/j.bioorg.2023.106424 ↗
74. Quaternized carbon quantum dots with broad-spectrum antibacterial activity for the treatment of wounds infected with mixed bacteria10.1016/j.actbio.2021.11.010 ↗
75. Design, Synthesis, and application of carbon dots with synergistic antibacterial activity10.3389/fbioe.2022.894100 ↗
76. Yet another similarity between mitochondrial and bacterial ribosomal small subunit biogenesis obtained by structural characterization of RbfA from S. aureus10.3390/ijms24032118 ↗
77. Quaternary ammonium carbon quantum dots as an antimicrobial agent against Gram-positive bacteria for the treatment of MRSA-infected pneumonia in mice10.1016/j.carbon.2020.03.009 ↗
78. Comprehensive transcriptomics and metabolomics revealed the antifungal mechanism of Cymbopogon citratus essential oil nanoemulsion against Fusarium solani10.1186/s40538-023-00511-7 ↗
79. Dynamics of organic acid exudation and rhizobacteria in maize rhizosphere respond to N-CDs10.1016/j.scitotenv.2023.166500 ↗
80. Multiple fluorescence response behaviours to proteins/bacteria and selective antibacterial activity of cetylpyridinium chloride (CPC)-based cationic carbon dots10.1039/D2RA04084K ↗
81. Structural characterization, functional profiling, and mechanism study of four antimicrobial peptides for antibacterial and anticancer applications10.1021/acs.langmuir.2c02526 ↗
82. Enzyme function and evolution through the lens of bioinformatics10.1042/BCJ20220405 ↗
83. Enzyme function prediction using contrastive learning10.1126/science.adf2465 ↗
84. Identification and prioritization of potential therapeutic molecules against LpxA from Acinetobacter baumannii-A computational study
85. Selective inactivation of Gram-negative bacteria by carbon dots derived from natural biomass: Artemisia argyi leaves10.1039/C9TB02735A ↗
86. Stability of lipases in miniemulsion systems: Correlation between secondary structure and activity10.1016/j.enzmictec.2018.03.003 ↗
87. A Candida albicans mutant impaired in the utilization of N-acetylglucosamine
88. Peptidoglycan deacetylation controls type IV secretion and the intracellular survival of the bacterial pathogen Legionella pneumophila10.1073/pnas.2119658120 ↗
89. Antibiotics and antibiotic resistance-mur ligases as an antibacterial target10.3390/molecules28248076 ↗
90. Light-trapping texture bio-hydrogel with anti-biofouling and antibacterial properties for efficient solar desalination10.1016/j.cej.2023.141430 ↗
91. Catalytic evaluation and in vitro bacterial inactivation of graphitic carbon nitride/carbon sphere doped bismuth oxide quantum dots with evidential in silico analysis10.1039/D3RA04664H ↗
92. Preparations of antibacterial yellow-green-fluorescent carbon dots and carbon dots-lysozyme complex and their applications in bacterial imaging and bacteria/biofilm inhibition/clearance10.1016/j.ijbiomac.2023.123303 ↗
93. Pyrogallol impairs staphylococcal biofilm formation via induction of bacterial oxidative stress10.1093/jambio/lxad270 ↗
94. Staphylococcus aureus delta toxin modulates both extracellular membrane vesicle biogenesis and amyloid formation10.1128/mbio.01748-23 ↗
95. Structure of biofilm-forming functional amyloid PSMalpha1 from Staphylococcus aureus10.1073/pnas.2406775121 ↗
96. The molecular mechanism of PSMα3 aggregation: A new view10.1021/acs.jpcb.3c03806 ↗
97. Anti-biofilm activity of graphene quantum dots via self-assembly with bacterial amyloid proteins10.1021/acsnano.8b09403 ↗
98. Single-mode termination of phage transcriptions, disclosing bacterial adaptation for facilitated reinitiations10.1093/nar/gkae620 ↗
99. Role of DNA double-strand break formation in gyrase inhibitor-mediated killing of nonreplicating persistent mycobacterium tuberculosis in caseum10.1021/acsinfecdis.4c00499 ↗
100. Actions of a novel bacterial topoisomerase inhibitor against neisseria gonorrhoeae gyrase and topoisomerase IV: Enhancement of double-stranded DNA breaks10.3390/ijms241512107 ↗